Odyssey Health, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Odyssey Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-04-30 was $50.04K.
- Odyssey Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-10-31 was $144.00K.
- Odyssey Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-10-31 was $78.69K.
- Odyssey Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-04-30 was $100.00K.
- Odyssey Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $1.00M, a 109.75% increase from fiscal 2023.
- Odyssey Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $478.00K.
- Odyssey Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $267.50K.
- Odyssey Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $33.60K, a 50.00% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-04-30 | $50.04K 10-Q · filed 2026-06-12 | |
| 2025-10-31 | $144.00K 10-Q · filed 2026-06-12 | |
| 2024-07-31 | $1.00M 10-K · filed 2025-10-29 | |
| 2023-10-31 | $78.69K 10-Q · filed 2023-12-15 | |
| 2023-07-31 | $478.00K 10-K · filed 2024-11-13 | |
| 2023-04-30 | $100.00K 10-Q · filed 2024-06-14 | |
| 2023-01-31 | $300.00K 10-Q · filed 2024-06-14 | |
| 2020-10-31 | $107.00K 10-Q · filed 2022-06-14 | |
| 2020-07-31 | $267.50K 10-K · filed 2021-10-29 | |
| 2018-07-31 | $33.60K 10-K/A · filed 2020-11-13 | |
| 2017-07-31 | $22.40K 10-K · filed 2018-12-12 |